InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline Pharmaceutical Investing
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 Life Science Investing
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update Life Science Investing
GOSS: Announces Topline Results for Phase 3 PROSERA Trial -- LEVI & KORSINSKY, LLP Life Science Investing
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Pharmaceutical Investing
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis Life Science Investing
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results Life Science Investing
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 Life Science Investing
Minerva Neurosciences to Participate in The Citizens Life Sciences Conference Pharmaceutical Investing
